Using native FGF21, FGF21 analogues or metformin to stimulate FGF21 production, several experimental studies have also implicated the metabolic bioactivities of FGF21 against NAFLD 14-16. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.